ARCHIVES

Inhibitor Reduces Spleen Size By 35 Percent or More in Phase III

This article is from The Cancer Letter archive.

Vol. 36 No. 6 | June 28, 2013

Download PDF Visit The Full Archive

Related Articles

NTP Board Okays Modification Of Bioassay Protocols

April 9, 1982

Pitt Inquiry Panel Proceedings Suspended, ORI To Take Over NSABP Investigation

July 22, 1994

Normal Routines Dramatically Altered In Days Since Sept. 11 Terrorist Attacks.

September 21, 2001

Recombinant Protein C Cuts Risk Of Sepsis Death

February 22, 2002

In Brief: Pardee, Durant Head AASR, ASCO; Sartorell, Hellman Presidents Elect; ONS Reelects Johnson

May 31, 1985

Omnibus bill recissions would cut $28 million from NCI FY04 budget.

January 9, 2004